Literature DB >> 28096911

Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome.

Dean A Tripp1, J Curtis Nickel1, Adrijana Krsmanovic1, Michel Pontari2, Robert Moldwin3, Robert Mayer4, Lesley K Carr5, Claire C Yang6, Jorgen Nordling7.   

Abstract

INTRODUCTION: We sought to evaluate psychosocial factors as predictors of suicidal ideation (SI) in a tertiary care outpatient sample of women suffering from interstitial cystitis/bladder pain syndrome (IC/BPS).
METHODS: The patients are women managed at tertiary care centres (n=190). Controls were recruited from the community (n=117). Both groups completed questionnaires on demographics, pain (McGill Pain Questionnaire), IC/BPS symptoms, and psychological variables. Univariate and multivariate hierarchical regression modelling was conducted to examine the strength of associations and unique effects of psychosocial variables on patient SI.
RESULTS: Compared to 6% in healthy controls, 23% of patients endorsed SI in the past two weeks. Correlations between SI, depression, and catastrophizing across controls and cases show that for controls, SI is associated with greater pain (0.31; p<0.01) and depression only (0.59; p<0.01). For tertiary care centre cases, SI is associated with pain (0.24; p<0.01), depression (0.64; p<0.01), and catastrophizing (0.35; p<0.01). Regression analyses indicated that psychosocial variables accounted for a significant amount of variance over and above IC/BPS symptoms. Catastrophizing (i.e., helplessness) about pain and depression were significant univariate predictors of SI, but only depression predicted SI in multivariable analyses.
CONCLUSIONS: Limitations of this study include its cross-sectional design and primarily correlation-based statistics. The present study is the first to implicate multiple psychosocial risk factors over and above IC/BPS-specific symptoms and patient pain experience in SI in women with IC/BPS. Depression in particular is uniquely important in predicting suicidality. These results support a multidisciplinary, proactive approach to IC/BPS involving not only treatment of disease symptoms, but also early detection/treatment of associated psychosocial problems.

Entities:  

Year:  2016        PMID: 28096911      PMCID: PMC5167592          DOI: 10.5489/cuaj.3892

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  27 in total

1.  Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.

Authors:  R C Kessler; G Borges; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1999-07

Review 2.  The impact of physical pain on suicidal thoughts and behaviors: Meta-analyses.

Authors:  Raffaella Calati; Camelia Laglaoui Bakhiyi; Sylvaine Artero; Mark Ilgen; Philippe Courtet
Journal:  J Psychiatr Res       Date:  2015-09-11       Impact factor: 4.791

Review 3.  The case against no-suicide contracts: the commitment to treatment statement as a practice alternative.

Authors:  M David Rudd; Michael Mandrusiak; Thomas E Joiner
Journal:  J Clin Psychol       Date:  2006-02

4.  The interstitial cystitis symptom index and problem index.

Authors:  M P O'Leary; G R Sant; F J Fowler; K E Whitmore; J Spolarich-Kroll
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

5.  Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Yanlin Wang; Mark S Litwin; Mary McNaughton-Collins; J Richard Landis; Richard B Alexander; Anthony J Schaeffer; Michael P O'Leary; Michel A Pontari; Jackson E Fowler; Leroy M Nyberg; John W Kusek
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

6.  Depressive symptoms and quality of life in patients with interstitial cystitis.

Authors:  Nan E Rothrock; Susan K Lutgendorf; Anna Hoffman; Karl J Kreder
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

7.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

8.  The experience of chronic nonmalignant pain.

Authors:  L S Hitchcock; B R Ferrell; M McCaffery
Journal:  J Pain Symptom Manage       Date:  1994-07       Impact factor: 3.612

9.  Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls.

Authors:  Dean A Tripp; J Curtis Nickel; Jennifer Wong; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Ragi Doggweiler; Claire C Yang; Nagendra Mishra; Jorgen Nordling
Journal:  Eur Urol       Date:  2012-05-18       Impact factor: 20.096

10.  Catastrophizing as a cognitive vulnerability factor related to depression in workers' compensation patients with chronic musculoskeletal pain.

Authors:  Eun-Jeong Lee; Ming-Yi Wu; Gloria K Lee; Gladys Cheing; Fong Chan
Journal:  J Clin Psychol Med Settings       Date:  2008-06-18
View more
  11 in total

Review 1.  Managing psychosocial correlates of urologic chronic pelvic pain syndromes: Advice from a urology pain psychologist.

Authors:  Dean A Tripp
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

2.  Psychosocial co-morbidities in Interstitial Cystitis/Bladder Pain syndrome (IC/BPS): A systematic review.

Authors:  Lindsey C McKernan; Colin G Walsh; William S Reynolds; Leslie J Crofford; Roger R Dmochowski; David A Williams
Journal:  Neurourol Urodyn       Date:  2017-10-09       Impact factor: 2.696

3.  Relationship of Pain Catastrophizing With Urinary Biomarkers in Women With Bladder Pain Syndrome.

Authors:  Alex Soriano; Antoinette Allen; Anna P Malykhina; Uduak Andy; Heidi Harvie; Lily Arya
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-12-01       Impact factor: 2.091

4.  Cognition, Emotion, and the Bladder: Psychosocial Factors in bladder pain syndrome and interstitial cystitis (BPS/IC).

Authors:  Sula Windgassen; Lindsey McKernan
Journal:  Curr Bladder Dysfunct Rep       Date:  2020-01-31

5.  Qualitative Analysis of Treatment Needs in Interstitial Cystitis/Bladder Pain Syndrome: Implications for Intervention.

Authors:  Lindsey C McKernan; Kemberlee R Bonnet; Michael T M Finn; David A Williams; Stephen Bruehl; W Stuart Reynolds; Daniel Clauw; Roger R Dmochowski; David G Schlundt; Leslie J Crofford
Journal:  Can J Pain       Date:  2020-09-01

6.  Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS).

Authors:  Jeffrey M Lackner; James Jaccard; Brian M Quigley; Tova S Ablove; Teresa L Danforth; Rebecca S Firth; Gregory D Gudleski; Susan S Krasner; Christopher D Radziwon; Alison M Vargovich; J Quentin Clemens; Bruce D Naliboff
Journal:  Trials       Date:  2022-08-13       Impact factor: 2.728

Review 7.  Comorbidities of bladder pain syndrome in the context of the HITOP distress category: a systematic review and meta-analysis.

Authors:  Linda Fischer-Grote; Vera Fössing; Martin Aigner; Markus Boeckle; Elisabeth Fehrmann
Journal:  Int Urogynecol J       Date:  2022-03-09       Impact factor: 1.932

8.  Biopsychosocial predictors of suicide risk in patients with interstitial cystitis/bladder pain syndrome.

Authors:  Dean A Tripp; Joel Dueck; Ronald R Holden; Julia Moreau; R Christopher Doiron; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

9.  Association between Chronic Interstitial Cystitis and Herpes Zoster.

Authors:  Chao-Yu Hsu; Cheng-Li Lin; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

10.  Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic.

Authors:  Antonella Giannantoni; Emanuele Rubilotta; Matteo Balzarro; Marilena Gubbiotti
Journal:  Neurourol Urodyn       Date:  2020-11-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.